%0 Journal Article
%T Pharmacist counseling in a cohort of women with HIV and women at risk for HIV
%A Cocohoba JM
%A Althoff KN
%A Cohen M
%A Hu H
%A Cunningham CO
%A Sharma A
%A Greenblatt RM
%J Patient Preference and Adherence
%D 2012
%I Dove Medical Press
%R http://dx.doi.org/10.2147/PPA.S30797
%X rmacist counseling in a cohort of women with HIV and women at risk for HIV Original Research (1451) Total Article Views Authors: Cocohoba JM, Althoff KN, Cohen M, Hu H, Cunningham CO, Sharma A, Greenblatt RM Published Date June 2012 Volume 2012:6 Pages 457 - 463 DOI: http://dx.doi.org/10.2147/PPA.S30797 Received: 11 February 2012 Accepted: 23 February 2012 Published: 18 June 2012 Jennifer M Cocohoba,1 Keri N Althoff,2 Mardge Cohen,3 Haihong Hu,4 Chinazo O Cunningham,5 Anjali Sharma,6 Ruth M Greenblatt1,7 1University of California, San Francisco School of Pharmacy, San Francisco, CA; 2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; 3Department of Medicine, Stroger Hospital and Rush Medical College, Chicago, IL; 4Department of Medicine, Georgetown University, Washington, DC; 5Albert Einstein College of Medicine, Bronx, NY; 6SUNY Downstate Medical Center, Brooklyn, NY; 7University of California, San Francisco School of Medicine, San Francisco, CA, USA Background and methods: Achieving high adherence to antiretroviral therapy for human immunodeficiency virus (HIV) is challenging due to various system-related, medication-related, and patient-related factors. Community pharmacists can help patients resolve many medication-related issues that lead to poor adherence. The purpose of this cross-sectional survey nested within the Women＊s Interagency HIV Study was to describe characteristics of women who had received pharmacist medication counseling within the previous 6 months. The secondary objective was to determine whether HIV-positive women who received pharmacist counseling had better treatment outcomes, including self-reported adherence, CD4+ cell counts, and HIV-1 viral loads. Results: Of the 783 eligible participants in the Women＊s Interagency HIV Study who completed the survey, only 30% of participants reported receiving pharmacist counseling within the last 6 months. Factors independently associated with counseling included increased age (odds ratio [OR] 1.28; 95% confidence interval [CI] 1.07每1.55), depression (OR 1.75; 95% CI 1.25每2.45), and use of multiple pharmacies (OR 1.65; 95% CI 1.15每2.37). Patients with higher educational attainment were less likely to report pharmacist counseling (OR 0.68; 95% CI 0.48每0.98), while HIV status did not play a statistically significant role. HIV-positive participants who received pharmacist counseling were more likely to have optimal adherence (OR 1.23; 95% CI 0.70每2.18) and increased CD4+ cell counts (+43 cells/mm3, 95% CI 17.7每104.3) compared with those who had not received counseling, though these estimates did not achieve statistical significance. Conclusion: Pharmacist medication counseling rates are suboptimal in HIV-positive and at-risk women. Pharmacist counseling is an underutilized resource which may contribute to improved adherence and CD4+ counts, though prospective studies should be conducted to explore this effect further.
%K human immunodeficiency virus
%K acquired immunodeficiency syndrome
%K antiretroviral therapy
%K community pharmacy
%K pharmacy practice
%K women＊s health
%U https://www.dovepress.com/pharmacist-counseling-in-a-cohort-of-women-with-hiv-and-women-at-risk--peer-reviewed-article-PPA